JOHNSON

Surge Ventures Expands Board of Advisors with the Addition of Nimesh Mehta, Joseph Kuo, Brian Johnson and Ann Robinson

Retrieved on: 
Monday, January 22, 2024
Cloud, National Life Group, Bachelor, NCC, Research, Partner, LPL, University, Sale, Mehta, Doctor of Philosophy, NCC Group, Computer engineering, NTT, Farmer, Surge, JD, E-commerce, Samford University, Raymond James Morgan Keegan, Rheged, Insurance, Case Western Reserve University, Yale University, Software, Information security, Organization, Marketing, Senior, CISO, Security guard, Financial services, Software as a service, Business, CIO, Lumen Technologies, MBA, Investment, Lish, Lincoln National Corporation, New Board, Adviser, Lincoln, Government, QuantumScape, PayPal, LPL Financial, AmSouth Bancorporation, CPA, Internet, SVP, Management

MENLO PARK, Calif., Jan. 22, 2024 /PRNewswire/ -- Surge Ventures (Surge), a new SaaS venture studio initially targeting the financial services and wealth management industry, announced the expansion of its advisory board comprised of wealth management and FinTech industry executives to help guide the firm as it continues its journey to find, fund and nurture the leading technologies of tomorrow. New Board members are Nimesh Mehta, Joseph Kuo, Brian Johnson and Ann Robinson. They join current members, Jason Lish (Chairman), Dr. Neil Daswani, John Rostern, Larry Roth, Matthew Martin, Geoff Moore.

Key Points: 
  • New Board members are Nimesh Mehta, Joseph Kuo, Brian Johnson and Ann Robinson.
  • Surge has established a strong Industry Council comprised of seasoned executives and influencers from across the FinTech and wealth management sectors.
  • The new Board members will add their voices as strategic counselors to Surge's leadership, as the firm executes its vision and growth plans.
  • "I am extremely excited to welcome Nimesh, Joe, Brian and Ann to the Surge Ventures Industry Council," said Lish.

Cowboy Clean Fuels Announces Significant Funding Award to Support Commercialization of Technology and Build Out of Initial Project in Wyoming

Retrieved on: 
Wednesday, January 17, 2024
Carbon, CO2, Coalbed methane, Wyoming Legislature, Natural gas, WEA, Research, Digestion, Powder River Basin, EMF, Energy, CCUS, CDR, RNG, Methane, University, CBM, CCF, Atmosphere, Business development, Tax, Climate change, Investment, Environmental quality, Private sector, Renewable energy

GILLETTE, Wyo., Jan. 17, 2024 /PRNewswire/ -- Cowboy Clean Fuels, LLC ("CCF," "we," "us," "our," or "the Company"), a premier energy technology company formed to simultaneously, permanently sequester carbon dioxide removed from the atmosphere and produce carbon-negative, renewable natural gas ("RNG") from readily available agricultural byproducts utilizing proprietary, patented technology, today announced that it has been awarded approximately $7.8 million from the Wyoming Energy Authority ("WEA") through the Energy Matching Funds ("EMF") program.  In addition, CCF's lead investor, Machan Investments ("Machan"), committed an additional $7.8 million in equity capital to match and enable the WEA funding. The WEA funds and the investor funds from Machan, totaling approximately $15.6 million, will support the commercialization of CCF's technology and the build-out of its first commercial project in Wyoming, the Triangle Unit Renewable Energy and Carbon Capture and Storage ("TRECCS") project. After receiving a Class V Underground Injection Control permit from the Wyoming Department of Environmental Quality in late 2023, the first-of-its-kind TRECCS project is permitted and ready to sequester CO2 and produce RNG at commercial volumes.

Key Points: 
  • In addition, CCF's lead investor, Machan Investments ("Machan"), committed an additional $7.8 million in equity capital to match and enable the WEA funding.
  • These funds come at a critical juncture as we move into the commercial phase of our first project.
  • Wyoming is committed to an all-of-the-above energy strategy that includes advancing the carbon economy.
  • The Company's world-class leadership team has over 100 years of experience in clean energy technology commercialization, upstream gas operations, and large-scale energy project development.

Johnson Controls Announces First Quarter 2024 Earnings Conference Call Webcast

Retrieved on: 
Tuesday, January 16, 2024
Telephone, JCI, Webcast

CORK, Ireland, Jan. 16, 2024 /PRNewswire/ -- Johnson Controls International plc (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, announces the following webcast:

Key Points: 
  • CORK, Ireland, Jan. 16, 2024 /PRNewswire/ -- Johnson Controls International plc (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, announces the following webcast:
    How: The conference call for investors can be accessed in the following ways:
    Live via webcast at http://investors.johnsoncontrols.com/news-and-events/events-and-presenta... Note: A slide presentation will be available that morning for downloading.
  • Replay:  The replay can be accessed in the following ways:
    Replay via webcast – if you are unable to participate during the live webcast, the call will be archived at http://investors.johnsoncontrols.com/news-and-events/events-and-presenta... .
  • Replay via telephone – by dialing 877-344-7529 (in the United States) or +1-412-317-0088 (outside the United States), passcode 7320673, from 10:30 a.m. (ET) on Jan. 30, 2024, until 11:59 p.m. (ET) on Feb. 6, 2024.

LIfT BioSciences appoints Dr Bo Rode Hansen and Dr Marco Gottardis to its Board of Directors

Retrieved on: 
Thursday, December 21, 2023
DAS, RNA, Drug resistance, Prostate, Henley Business School, Research, RNA therapeutics, Janssen, Roche, Jan Vansina, Lift, Master of Science, AMR, MBA, Doctor of Philosophy, Therapy, Seed, Columbia University, University, Innovation, BMS, Neurology, IPO, Sun Pharma, Bristol Myers Squibb

London, 21 December 2023 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy, today announces the appointments of Dr Bo Rode Hansen PhD, MBA and Dr Marco Gottardis, PhD as Non-Executive Directors of its Board.

Key Points: 
  • London, 21 December 2023 – LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy, today announces the appointments of Dr Bo Rode Hansen PhD, MBA and Dr Marco Gottardis, PhD as Non-Executive Directors of its Board.
  • He currently advises Novo Seeds (Novo Holdings), a life science investment company and consults for different life science, biotech, and investment companies.
  • He previously served as the CEO and President of Scandion Oncology A/S, a Danish cancer drug resistance company.
  • Alex Blyth, Chief Executive Officer of LIfT BioSciences commented: “On behalf of the Board, I’m delighted to welcome both Bo and Marco onto our Board of Directors as key hires for LIfT’s next phase as we move into license deals.

Judith A. Reinsdorf and Katherine M. Sandstrom Named to Toll Brothers Board of Directors

Retrieved on: 
Wednesday, December 13, 2023
Pharmacia, NPO, Trust, Heitman, Trustee, Healthpeak Properties, National Association, Tyco International, Therapy, EGP, University, JCI, UE, Toll Brothers, PEAK, Bard (company), Management

FORT WASHINGTON, Pa., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE: TOL) ( TollBrothers.com ), the nation’s leading builder of luxury homes, today announced that Judith A. Reinsdorf and Katherine M. Sandstrom have joined the Company’s Board of Directors.

Key Points: 
  • FORT WASHINGTON, Pa., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE: TOL) ( TollBrothers.com ), the nation’s leading builder of luxury homes, today announced that Judith A. Reinsdorf and Katherine M. Sandstrom have joined the Company’s Board of Directors.
  • She is also on the Board of Trustees of the University of Rochester and the board of the New Jersey Chapter of the National Association of Corporate Directors.
  • Douglas C. Yearley, Jr., chairman and chief executive officer, stated: “We are very pleased and excited to welcome both Judy and Kathy to the Toll Brothers Board of Directors.
  • We wish him all the best and are deeply appreciative of his many years of distinguished service to Toll Brothers.”

12th Annual Chief Medical Officer Summit 360° Agenda and Keynotes Announced from The Conference Forum

Retrieved on: 
Wednesday, December 20, 2023
Conference, Science, Drug development, CMO, MIT, MBA, Therapy, CMOS, Organization, Intelligence

NEW YORK, Dec. 20, 2023 /PRNewswire-PRWeb/ -- The Conference Forum is pleased to announce the agenda and keynote speakers for the 12th annual Chief Medical Officer Summit 360°, the only conference dedicated to supporting the role of the Chief Medical Officer in emerging biotechs. The CMO Summit 360° will take place in Boston on April 17-18.

Key Points: 
  • The Conference Forum is pleased to announce the agenda and keynote speakers for the 12th annual Chief Medical Officer Summit 360°, the only conference dedicated to supporting the role of the Chief Medical Officer in emerging biotechs.
  • NEW YORK, Dec. 20, 2023 /PRNewswire-PRWeb/ -- The Conference Forum is pleased to announce the agenda and keynote speakers for the 12th annual Chief Medical Officer Summit 360°, the only conference dedicated to supporting the role of the Chief Medical Officer in emerging biotechs.
  • The biotech Chief Medical Officer is responsible for the strategic and operational leadership throughout R&D.
  • "This year's CMO Summit already has over 65 biotech Chief Medical Officers speaking in 35 sessions."

Johnson Controls Reports Q4 and FY23 Results Highlighted by Strong Sales Growth and Margin Expansion; Initiates FY24 Guidance

Retrieved on: 
Tuesday, December 12, 2023
Table, JCI, Growth, EBIT, NYSE, GAAP, Tax, Digital, EBITA, EPS

Excluding special items, adjusted EPS from continuing operations was $1.05, up 6% versus the prior year period (see attached footnotes for non-GAAP reconciliation).

Key Points: 
  • Excluding special items, adjusted EPS from continuing operations was $1.05, up 6% versus the prior year period (see attached footnotes for non-GAAP reconciliation).
  • Sales in the quarter of $6.9 billion increased 3% compared to the prior year on an as reported basis and grew 2% organically.
  • This press release includes forward-looking statements regarding organic revenue growth, adjusted segment EBITA margin improvement and adjusted EPS, which are non-GAAP financial measures.
  • The unavailable information could have a significant impact on the Company's fiscal 2024 first quarter and full year GAAP financial results.

Johnson Controls Announces Quarterly Dividend

Retrieved on: 
Wednesday, December 6, 2023
JCI, NYSE, Holding company

CORK, Ireland, Dec. 6, 2023 /PRNewswire/ -- The board of directors of Johnson Controls International plc (NYSE: JCI), the global leader in smart, healthy and sustainable buildings, has approved a regular quarterly dividend of $0.37 per share of common stock, payable on Jan. 12, 2024, to shareholders of record at the close of business on Dec. 18, 2023.

Key Points: 
  • CORK, Ireland, Dec. 6, 2023 /PRNewswire/ -- The board of directors of Johnson Controls International plc (NYSE: JCI), the global leader in smart, healthy and sustainable buildings, has approved a regular quarterly dividend of $0.37 per share of common stock, payable on Jan. 12, 2024, to shareholders of record at the close of business on Dec. 18, 2023.
  • Johnson Controls has paid a consecutive dividend since 1887.

Johnson Controls Announces Fourth Quarter 2023 Earnings Conference Call Webcast

Retrieved on: 
Wednesday, November 29, 2023
Webcast, JCI, NYSE, Telephone

CORK, Ireland, Nov. 29, 2023 /PRNewswire/ -- Johnson Controls International plc (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, announces the following webcast:

Key Points: 
  • CORK, Ireland, Nov. 29, 2023 /PRNewswire/ -- Johnson Controls International plc (NYSE: JCI), the global leader for smart, healthy and sustainable buildings, announces the following webcast:
    How: The conference call for investors can be accessed in the following ways:
    Live via webcast at http://investors.johnsoncontrols.com/news-and-events/events-and-presenta... Note: A slide presentation will be available that morning for downloading.
  • Replay:  The replay can be accessed in the following ways:
    Replay via webcast – if you are unable to participate during the live webcast, the call will be archived at http://investors.johnsoncontrols.com/news-and-events/events-and-presenta... .
  • Replay via telephone – by dialing 877-344-7529 (in the United States) or +1-412-317-0088 (outside the United States), passcode 6984699, from 10:30 a.m. (ET) on Dec.12, 2023, until 11:59 p.m. (ET) on Dec.19, 2023.

Interventional Spine Devices Market to grow by USD 3.07 billion from 2023 to 2028; North America to account for 47% of market growth- Technavio

Retrieved on: 
Monday, November 20, 2023
Phacoemulsification, Osteoporosis, Augmented fifth, Spinal fusion, Abbott Laboratories, Chronic pain, Prevalence, Stryker Corporation, ROW, Spine, Spondylolisthesis, Laboratory, Patient, Research, Otoscope, USD, VCF, Zimmer Biomet, Medtronic, Proclaim!, Trauma, Pain, Scoliosis, Growth, SE, Radiofrequency ablation, Family, Free, Dentistry, Retail, Speciality chemicals, Bookbinding

NEW YORK, Nov. 20, 2023 /PRNewswire/ -- The interventional spine devices market is expected to grow by USD 3.07 billion from 2023 to 2028.

Key Points: 
  • NEW YORK, Nov. 20, 2023 /PRNewswire/ -- The interventional spine devices market is expected to grow by USD 3.07 billion from 2023 to 2028.
  • North America is estimated to contribute 47% to the growth of the global market during the forecast period.
  • Detailed information on factors that will drive the growth of the interventional spine devices market between 2023 and 2028.
  • Growth of the interventional spine devices market across North America, Europe, Asia, and ROW
    Comprehensive analysis of factors that will challenge the growth of interventional spine device market companies.